326.20
price down icon1.44%   -4.78
after-market After Hours: 326.94 0.74 +0.23%
loading
Waters Corp stock is traded at $326.20, with a volume of 673.32K. It is down -1.44% in the last 24 hours and up +13.83% over the past month. Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.
See More
Previous Close:
$330.98
Open:
$333.06
24h Volume:
673.32K
Relative Volume:
0.61
Market Cap:
$32.02B
Revenue:
$3.17B
Net Income/Loss:
$642.63M
P/E Ratio:
30.30
EPS:
10.765
Net Cash Flow:
$516.49M
1W Performance:
+2.41%
1M Performance:
+13.83%
6M Performance:
-1.87%
1Y Performance:
+0.85%
1-Day Range:
Value
$324.63
$333.68
1-Week Range:
Value
$310.00
$333.68
52-Week Range:
Value
$275.05
$414.15

Waters Corp Stock (WAT) Company Profile

Name
Name
Waters Corp
Name
Phone
(508) 478-2000
Name
Address
34 MAPLE ST, MILFORD, MA
Name
Employee
7,900
Name
Twitter
@WatersCorp
Name
Next Earnings Date
2024-11-01
Name
Latest SEC Filings
Name
WAT's Discussions on Twitter

Compare WAT vs TMO, DHR, IDXX, A

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
WAT icon
WAT
Waters Corp
326.20 32.49B 3.17B 642.63M 516.49M 10.77
TMO icon
TMO
Thermo Fisher Scientific Inc
531.67 195.93B 44.56B 6.72B 6.29B 17.74
DHR icon
DHR
Danaher Corp
198.14 140.56B 24.57B 3.60B 5.26B 5.051
IDXX icon
IDXX
Idexx Laboratories Inc
580.76 46.39B 4.30B 1.06B 1.04B 13.08
A icon
A
Agilent Technologies Inc
119.77 34.02B 7.07B 1.29B 993.00M 4.5355

Waters Corp Stock (WAT) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-06-26 Upgrade Evercore ISI In-line → Outperform
Feb-10-26 Resumed Barclays Overweight
Feb-10-26 Resumed Citigroup Buy
Feb-10-26 Resumed Evercore ISI In-line
Jan-06-26 Initiated Guggenheim Buy
Jan-05-26 Initiated William Blair Outperform
Dec-10-25 Upgrade Wolfe Research Peer Perform → Outperform
Dec-02-25 Initiated Morgan Stanley Equal-Weight
Oct-08-25 Initiated Rothschild & Co Redburn Buy
Mar-31-25 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Mar-26-25 Upgrade Robert W. Baird Neutral → Outperform
Feb-13-25 Upgrade Scotiabank Sector Perform → Sector Outperform
Feb-10-25 Upgrade Barclays Underweight → Equal Weight
Jan-10-25 Upgrade Bernstein Mkt Perform → Outperform
Dec-23-24 Initiated Scotiabank Sector Perform
Oct-08-24 Upgrade Jefferies Hold → Buy
Aug-28-24 Initiated Wells Fargo Overweight
Aug-01-24 Upgrade Leerink Partners Market Perform → Outperform
Jun-03-24 Resumed Jefferies Hold
Nov-13-23 Downgrade Barclays Equal Weight → Underweight
Sep-28-23 Initiated Bernstein Mkt Perform
Jul-31-23 Downgrade Barclays Overweight → Equal Weight
Jul-31-23 Downgrade Evercore ISI Outperform → In-line
Dec-14-22 Initiated Deutsche Bank Hold
Aug-25-22 Initiated Credit Suisse Neutral
Jul-20-22 Initiated UBS Neutral
May-18-22 Initiated Barclays Overweight
May-17-22 Upgrade BofA Securities Underperform → Neutral
Apr-25-22 Upgrade Wells Fargo Underweight → Equal Weight
Oct-15-21 Resumed Cowen Market Perform
Jul-06-21 Upgrade Evercore ISI In-line → Outperform
Jan-07-21 Downgrade Wells Fargo Equal Weight → Underweight
Dec-17-20 Upgrade Cleveland Research Underperform → Buy
Dec-16-20 Upgrade Citigroup Sell → Neutral
Dec-02-20 Initiated Goldman Neutral
Nov-10-20 Initiated KeyBanc Capital Markets Sector Weight
Jul-28-20 Upgrade JP Morgan Underweight → Neutral
Jul-16-20 Upgrade Wells Fargo Underweight → Equal Weight
Jan-08-20 Downgrade Needham Hold → Underperform
Jan-08-20 Initiated Wells Fargo Underweight
Jan-07-20 Initiated Citigroup Sell
Nov-15-19 Initiated Stifel Hold
Oct-09-19 Downgrade Barclays Equal Weight → Underweight
Jul-16-19 Downgrade BofA/Merrill Neutral → Underperform
Jun-12-19 Downgrade Cleveland Research Neutral → Underperform
May-30-19 Initiated Wolfe Research Underperform
Jan-24-19 Downgrade Robert W. Baird Outperform → Neutral
Jan-03-19 Upgrade BofA/Merrill Underperform → Neutral
Jan-03-19 Initiated Needham Hold
Dec-12-18 Downgrade JP Morgan Neutral → Underweight
Nov-30-18 Downgrade Goldman Neutral → Sell
Oct-11-18 Upgrade Cleveland Research Sell → Neutral
View All

Waters Corp Stock (WAT) Latest News

pulisher
11:06 AM

WAT SEC FilingsWaters 10-K, 10-Q, 8-K Forms - Stock Titan

11:06 AM
pulisher
08:08 AM

Waters Corporation's Q1 2026 Earnings: What to Expect - Inkl

08:08 AM
pulisher
03:28 AM

Waters Corp stock (US94106L1098): Why its leadership in analytical instruments matters more now for - AD HOC NEWS

03:28 AM
pulisher
Apr 14, 2026

Waters Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Apr 14, 2026
pulisher
Apr 14, 2026

Waters prices $3.5B senior notes offering - MSN

Apr 14, 2026
pulisher
Apr 14, 2026

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules – Company AnnouncementFT.com - Financial Times

Apr 14, 2026
pulisher
Apr 13, 2026

Cardinal Capital Management's Waters Corp(WAT) Holding History - GuruFocus

Apr 13, 2026
pulisher
Apr 13, 2026

Waters Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch

Apr 13, 2026
pulisher
Apr 13, 2026

Big Picture: Will Waters Corporation outperform small cap indexes2026 Trends & Technical Pattern Recognition Alerts - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 13, 2026

Street Calls of the Week By Investing.com - Investing.com India

Apr 13, 2026
pulisher
Apr 12, 2026

IAWAI growth assumptions questioned as waters company prepares strategy - Waikato Times

Apr 12, 2026
pulisher
Apr 12, 2026

WAT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Apr 12, 2026
pulisher
Apr 11, 2026

Waters Corporation (NYSE: WAT) Reports First Quarter 2022 Financial Results - ADVFN

Apr 11, 2026
pulisher
Apr 11, 2026

Waters Corporation (NYSE: WAT) Reports First Quarter 2021 Financial Results - ADVFN

Apr 11, 2026
pulisher
Apr 10, 2026

Waters Corp Achieves Highest Daily Trading Volume of $270 Million, Rising 0.74% as Earnings Outlook Adjusts - Bitget

Apr 10, 2026
pulisher
Apr 10, 2026

Waters Corporation (WAT) stock price, news, quote and history - Yahoo Finance Australia

Apr 10, 2026
pulisher
Apr 10, 2026

WAT Earnings History & Surprises | EPS & Revenue Results | WATERS CORP (NYSE:WAT) - ChartMill

Apr 10, 2026
pulisher
Apr 09, 2026

Waters (NYSE: WAT) highlights BD acquisition, 7% 2025 growth and performance-linked executive pay - Stock Titan

Apr 09, 2026
pulisher
Apr 09, 2026

HARTFORD HEALTHCARE HLS FUND's Waters Corp(WAT) Holding History - GuruFocus

Apr 09, 2026
pulisher
Apr 09, 2026

WAT Stock Price, Quote & Chart | WATERS CORP (NYSE:WAT) - ChartMill

Apr 09, 2026
pulisher
Apr 08, 2026

Waters (WAT) Gains FDA Clearance for At-Home Cervical Cancer Scr - GuruFocus

Apr 08, 2026
pulisher
Apr 08, 2026

Waters Corp. stock outperforms competitors on strong trading day - MarketWatch

Apr 08, 2026
pulisher
Apr 08, 2026

Waters Corp Stock Surges on FDA Clearance: What Investors Need to Know Now - AD HOC NEWS

Apr 08, 2026
pulisher
Apr 08, 2026

Waters Stock Shoots Higher As FDA Clears At-Home Cervical Cancer Screening KitWaters (NYSE:WAT) - Benzinga

Apr 08, 2026
pulisher
Apr 08, 2026

Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay - Finviz

Apr 08, 2026
pulisher
Apr 08, 2026

US FDA approves Waters' at‑home cervical cancer screening kit - Reuters

Apr 08, 2026
pulisher
Apr 08, 2026

Waters (WAT) Gains FDA Approval for At-Home Cervical Cancer Scre - GuruFocus

Apr 08, 2026
pulisher
Apr 08, 2026

FDA clears at-home HPV kit as 60% of cervical cancer cases hit unscreened people - Stock Titan

Apr 08, 2026
pulisher
Apr 08, 2026

Waters Corp stock: What investors need to know in today's market - AD HOC NEWS

Apr 08, 2026
pulisher
Apr 07, 2026

[Form 4] WATERS CORP /DE/ Insider Trading Activity - Stock Titan

Apr 07, 2026
pulisher
Apr 07, 2026

Waters Corporation (NYSE:WAT) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Apr 07, 2026
pulisher
Apr 06, 2026

Evercore ISI upgrades Waters stock rating on achievable targets By Investing.com - Investing.com Australia

Apr 06, 2026
pulisher
Apr 06, 2026

Evercore ISI upgrades Waters stock rating on achievable targets - Investing.com

Apr 06, 2026
pulisher
Apr 06, 2026

Waters Corp : Evercore ISI Raises to Outperfo - Moomoo

Apr 06, 2026
pulisher
Apr 06, 2026

Manufacturing Excellence Awards 2026: Waters Corp. - Worcester Business Journal

Apr 06, 2026
pulisher
Apr 04, 2026

WAT Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai

Apr 04, 2026
pulisher
Apr 03, 2026

Waters Corporation (WAT) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 03, 2026
pulisher
Apr 02, 2026

Waters Corp (WAT) director gets deferred stock units grant - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

Director Heather Knight granted deferred Waters (NYSE: WAT) stock units - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

Waters Corp (MIL:1WAT) Bonds - GuruFocus

Apr 02, 2026
pulisher
Apr 01, 2026

Parkman Healthcare Partners LLC's Waters Corp(WAT) Holding History - GuruFocus

Apr 01, 2026
pulisher
Apr 01, 2026

Goldman Sachs Reinstates Buy Rating on Waters (WAT) Stock - GuruFocus

Apr 01, 2026
pulisher
Mar 31, 2026

Waters Corp. stock rises Tuesday, still underperforms market - MarketWatch

Mar 31, 2026
pulisher
Mar 31, 2026

Waters Corp (WAT) Expands After BD Diagnostic Solutions Acquisition - Insider Monkey

Mar 31, 2026
pulisher
Mar 30, 2026

Waters Corp (WAT) Trading Down 3.79% on Mar 30 - GuruFocus

Mar 30, 2026
pulisher
Mar 27, 2026

Waters Corp (LTS:0LTI) Bonds - GuruFocus

Mar 27, 2026
pulisher
Mar 27, 2026

Waters Corp. stock underperforms Friday when compared to competitors - MarketWatch

Mar 27, 2026
pulisher
Mar 27, 2026

CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know - Yahoo Finance

Mar 27, 2026
pulisher
Mar 27, 2026

Vanguard disaggregates holdings; Waters Corp shows 0% stake (WAT) - Stock Titan

Mar 27, 2026
pulisher
Mar 27, 2026

Waters (MIC:WAT-RM) NonCurrent Deferred Revenue : ₽0.00 Mil (As of Dec. 2025) - GuruFocus

Mar 27, 2026
pulisher
Mar 27, 2026

Waters Corp Stock: Analytical Instruments Leader Faces Growth Challenges Amid Sector Tailwinds - AD HOC NEWS

Mar 27, 2026

Waters Corp Stock (WAT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
A A
$119.77
price down icon 0.51%
IQV IQV
$178.10
price up icon 1.61%
$207.19
price down icon 3.47%
MTD MTD
$1,315.85
price down icon 1.91%
LH LH
$266.73
price down icon 0.80%
Cap:     |  Volume (24h):